Moreover, because the GBM cell membrane readily traverses the BBB due to the downregulation of the specific proteins (ZO-1 and claudin-5) in tight junctions55, such biomimetic nanoparticles achieve efficient BBB transportation and GBM targeting. The gene discussed is CLDN5; the disease is glioblastoma.